Soundarya Palanisamy is an Industry Advisor based in Germany and is part of the Health and Life Sciences Practice at SAS. She supports clients by providing guidance on their journey of digital transformation through the usage of AI, analytics and technology. She specializes in machine learning, text mining and analytical life cycle management enabling her to unlock insights that optimize processes and spearhead innovation in the healthcare and life sciences domains. From her previous experience, she possesses a profound understanding of regulatory data science.
Health care and life science organizations have always prioritized saving lives and now extend that commitment to environmental, social and governance (ESG) goals. They are not merely checking boxes, but genuinely pursuing long term impact for individuals, future generations and the planet. However, they must now elevate their ESG efforts to
The COVID-19 pandemic brought an enormous urgency to the life sciences sector. Companies vied for suitable treatments and in less than a year, COVID-19 vaccines were developed. This demonstrated clearly that the sector could move at speed when necessary. Though vaccines were supported by regulators, inefficiencies in vaccine and drug development were exposed.
